Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
Hirsh
J
J
Hamilton Civic Hospitals, Research Centre, ON, Canada.
Warkentin
T E
TE
Raschke
R
R
Granger
C
C
Ohman
E M
EM
Dalen
J E
JE
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016903:Drug Monitoring; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin